Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Vaccinations01:51

Vaccinations

52.0K
Overview
52.0K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Hybridoma Technology01:31

Hybridoma Technology

17.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A rapid human vaccine process development map outlining lessons learnt from ChAdOx1 nCoV-19 vaccine during the COVID-19 pandemic.

Vaccine·2025
Same author

Considerations for rapid development and licencing of conventional and platform technology veterinary vaccines.

Avian pathology : journal of the W.V.P.A·2022
Same author

How has Covid-19 changed our views of the One Health agenda?

The Veterinary record·2021
Same author

Spotlight on avian pathology: the importance of recombinant vector platform technologies in poultry vaccination.

Avian pathology : journal of the W.V.P.A·2021
Same author

A Veterinary Vaccine Development Process Map to assist in the development of new vaccines.

Vaccine·2020

Related Experiment Video

Updated: Feb 17, 2026

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.9K

Recent Advances in Vaccine Technologies.

Michael James Francis1

  • 1BioVacc Consulting Ltd, The Red House, 10 Market Square, Amersham, Buckinghamshire HP7 0DQ, UK.

The Veterinary Clinics of North America. Small Animal Practice
|December 9, 2017
PubMed
Summary

Recent advances in veterinary vaccine technologies are reviewed, covering inactivated/killed vaccines like subunit and peptide vaccines, and live/attenuated strategies including vector and nucleic acid vaccines.

Keywords:
AttenuatedDIVAInactivatedNucleic acidPeptideSubunitVaccinesVector

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Related Experiment Videos

Last Updated: Feb 17, 2026

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Area of Science:

  • Veterinary Medicine
  • Immunology
  • Vaccinology

Background:

  • Vaccine development is crucial for animal health and disease prevention.
  • Traditional vaccine technologies face limitations in efficacy and safety.
  • Emerging technologies offer new avenues for improved veterinary vaccines.

Purpose of the Study:

  • To review recent advancements in vaccine technologies for veterinary applications.
  • To highlight key inactivated/killed and live/attenuated vaccine strategies.
  • To discuss the potential of novel vaccine platforms in animal health.

Main Methods:

  • Review of current literature on veterinary vaccine technologies.
  • Categorization of vaccines into inactivated/killed and live/attenuated approaches.
  • Discussion of specific vaccine types such as subunit, peptide, vector, and nucleic acid vaccines.

Main Results:

  • Inactivated/killed vaccines discussed include split-product, subunit, recombinant subunit/protein, and peptide vaccines.
  • Live/attenuated vaccines covered encompass modified live marker, live vector, and nucleic acid vaccines.
  • Recent technological progress enhances vaccine efficacy, safety, and specificity.

Conclusions:

  • Novel vaccine technologies hold significant promise for advancing veterinary medicine.
  • These innovations can lead to improved disease control and animal welfare.
  • Continued research and development are essential for harnessing the full potential of new vaccine platforms.